Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2010
11/23/2010CA2252565C Dna vaccine formulations
11/23/2010CA2194501C Method of regulating immune function
11/18/2010WO2010132872A1 Combination therapies and methods using anti-cd3 modulating agents and anti-tnf antagonists
11/18/2010WO2010132764A2 Live-attenuated compositions for bacterial infections
11/18/2010WO2010132725A2 Cyclin dependent kinase inhibitors and methods of use
11/18/2010WO2010132561A2 New human rotavirus strains and vaccines
11/18/2010WO2010131738A1 Azetidine compound and medicinal use thereof
11/18/2010WO2010131695A1 Modified double-stranded rna
11/18/2010WO2010130799A2 Method for impregnation with supercritical co2
11/18/2010WO2010130713A1 Specialized medical nutrition for surgical and trauma patients containing probiotics
11/18/2010WO2010130710A1 Complete liquid nutrition for children at the age of 1-10 years comprising probiotics
11/18/2010WO2010130704A1 Oral nutritional supplement comprising probiotics
11/18/2010WO2010130702A1 Infant and young children feeding formula comprising probiotics for infants and young children
11/18/2010WO2010130701A1 Specialized nutritional formula for adult patients with gastrointestinal intolerance containing probiotics
11/18/2010WO2010130700A1 Nutritionally balanced standard tube feeding formula containing probiotics
11/18/2010WO2010130699A1 Probiotic containing modules for tube feeding
11/18/2010WO2010130697A1 Oral nutritional supplement for children comprising probiotics
11/18/2010WO2010130663A1 Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
11/18/2010WO2010130662A1 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS
11/18/2010WO2010130661A1 Prevention and treatment of allergic diarrhoea
11/18/2010WO2010130660A1 Non-replicating micro-organisms and their immune boosting effect
11/18/2010WO2010130638A1 Sulfonamide compounds, pharmaceutical compositions and uses thereof
11/18/2010WO2010130629A1 Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc
11/18/2010WO2010130466A1 Sulphated hyaluronic acids as regulator agents of the cytokine activity
11/18/2010WO2010130224A1 Thiophene derivatives
11/18/2010WO2010130069A1 Use of pharmaceutical composition for preparing medicine for treating autoimmune disease
11/18/2010WO2010102824A3 Sodium salt of 5-cyclopropyl-2-{[2-(2,6- difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as dhodh inhibitor
11/18/2010WO2010101627A3 Methods and systems for treatment and/or diagnosis
11/18/2010WO2010033426A3 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
11/18/2010US20100292791 Fully synthetic implantable multi-phased scaffold
11/18/2010US20100292456 Rna interference mediating small rna molecules
11/18/2010US20100292345 Therapeutic uses of cannabigerol
11/18/2010US20100292320 Benzofuran anilide histone deacetylase inhibitors
11/18/2010US20100292307 Construct
11/18/2010US20100292257 Uses of 2-[piperidinyl] methyl-2, 3-dihydroimidazo [1,2-c] quinazolin-5 (6h)-one for providing an analgesic effect, anti-allergic effect and histamine h1 receptor antagonism effect
11/18/2010US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses
11/18/2010US20100292234 Triazole fused heteroaryl compounds and methods of use thereof
11/18/2010US20100292233 Dihydro-1h-pyrrolo[1,2-a]indol-1-yl carboxylic acid derivatives which act as s1p1 agonists
11/18/2010US20100292213 Anti-Inflammatory Agents
11/18/2010US20100292195 Low burst polymers and methods to produce polymer
11/18/2010US20100292164 Dimerized peptide
11/18/2010US20100292148 Targeted polylysine dendrimer therapeutic agent
11/18/2010US20100291628 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost
11/18/2010US20100291218 Immunomodulatory compositions, formulations, and methods for use thereof
11/18/2010US20100291189 Method for producing a membrane protein
11/18/2010US20100291177 Prevention of staphylococcus biofilm formation
11/18/2010US20100291156 Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
11/18/2010US20100291155 Allergy vaccine composition for mucosal administration
11/18/2010US20100291154 Composition for inhibition of transplant rejection containing the cordyceps mycellia extract as an active ingredient
11/18/2010US20100291149 Attenuated listeria spp. and methods for using the same
11/18/2010US20100291147 Recombinant rsv antigens
11/18/2010US20100291146 Method of eliciting an immune response against pandemic influenza virus
11/18/2010US20100291145 Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
11/18/2010US20100291142 Bacterial Artificial Chromosome Containing Feline Herpes Virus Type 1 Genome and Uses Thereof
11/18/2010US20100291140 Antibiotic resistance free listeria strains and methods for constructing and using same
11/18/2010US20100291138 Vaccine
11/18/2010US20100291134 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same
11/18/2010US20100291128 Novel compositions and vaccines against influenza a and influenza b infections
11/18/2010US20100291125 Eta-1 gene and methods for use
11/18/2010US20100291123 T Cell Receptor CDR3 Sequences and Methods for Detection
11/18/2010US20100291122 Method for enhancing immune response with peptide
11/18/2010US20100291121 Tumour-Specific Animal Proteins
11/18/2010US20100291119 Alpha B crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
11/18/2010US20100291115 Pharmaceutical composition for the sublingual administration of vaccines, method for the preparation of the same and uses thereof
11/18/2010US20100291114 Crystal structures and methods using same
11/18/2010US20100291110 Compositions and Methods for Regulating NK Cell Activity
11/18/2010US20100291109 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity
11/18/2010US20100291104 Bordetella outer-membrane protein antigens and methods of making and using the same
11/18/2010US20100291102 Therapeutic Agent
11/18/2010US20100291101 New anti-irc85 monoclonal antibody; and composition comprising the same for preventing and treating tuberculosis or enteritis disease; and the use thereof
11/18/2010US20100291095 Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies
11/18/2010US20100291093 Antibody-mediated disruption of quorum sensing in bacteria
11/18/2010US20100291089 Ligand of regulating immune response, and use thereof in treating an immune response-related disease
11/18/2010US20100291085 Antibodies to ox-2/cd200 and uses thereof in inhibiting immune responses
11/18/2010US20100291084 Use of il-23 antagonists for treatment of infection
11/18/2010US20100291082 Antigen presenting cell targeted anti-viral vaccines
11/18/2010US20100291081 Rage fusion proteins
11/18/2010US20100291075 Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Neutralizing Antibodies
11/18/2010US20100291073 Methods of reducing eosinophil levels
11/18/2010US20100291070 Type iii secretion system component protein pa1698 of pseudomonas aeruginosa
11/18/2010US20100291063 Protease inhibition
11/18/2010US20100291054 Novel regulatory t cells and uses thereof
11/18/2010US20100291043 Il-12 immunotherapy for cancer
11/18/2010US20100291042 Multipotent stem cells and uses thereof
11/18/2010US20100291037 Immunogenicity using a combination of dna and vaccinia virus vector vaccines
11/18/2010US20100291036 Compositions and methods for modulating vascular endothelial growth factor c (vegf-c) expression
11/18/2010US20100291030 Use of il-28 and il-29 to treat cancer and autoimmune disorders
11/18/2010US20100290994 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders
11/18/2010US20100290993 Antibodies to IL-6 and use thereof
11/18/2010US20100290992 Nanoparticle nucleic acid binding compound conjugates forming i-motifs
11/18/2010DE102009022046A1 Entfärbte Extrakte der Pflanze Pandanus conoideus Discolored extracts of the plant Pandanus conoideus
11/18/2010CA2799081A1 Vaccine immunotherapy
11/18/2010CA2763359A1 New human rotavirus strains and vaccines
11/18/2010CA2761917A1 Method for detoxification of lipopolysaccharide (lps) or of lipid a of gram-negative bacteria
11/18/2010CA2761916A1 Method for admixing the lipopolysaccharide (lps) of gram-negative bacteria
11/18/2010CA2761896A1 Cyclin dependent kinase inhibitors and methods of use
11/18/2010CA2761885A1 Methods and compositions for treating lupus
11/18/2010CA2761845A1 Thiophene[3,4-c]pyrrole pde4 mediators
11/18/2010CA2761691A1 Specialized medical nutrition for surgical and trauma patients containing probiotics
11/18/2010CA2761689A1 Specialized nutritional formula for adult patients with gastrointestinal intolerance containing probiotics
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 1172